Synapse Open Synapse
Biology

ArriVent collapses on disappointing lung cancer data

BioPharma Dive · · 2 min read

More than half of the company’s value was wiped out by findings that appear to erase a chance to battle Johnson & Johnson and others for market share.

Latest from BioPharma Dive